L Feng, Z Liu, C Li, Z Li, X Lou, L Shao… - The Lancet Digital …, 2022 - thelancet.com
… applied radiomicsanalysis to predict pathologicalcomplete … of radiomics MRI and biopsy slides enhanced the prediction of tumour regression grade to neoadjuvantchemoradiotherapy …
V Nardone, A Reginelli, R Grassi, G Vacca… - Cancers, 2022 - mdpi.com
… frequency of completepathologicalresponses and, … to neoadjuvantchemoradiotherapy (C-RT) and subsequently, to radical surgery. In particular, we carried out a retrospective analysis …
V Bourbonne, U Schick, O Pradier, D Visvikis… - Cancers, 2023 - mdpi.com
… Adding neoadjuvantchemoradiotherapy (CRT) with a total dose of 50–56 … pathological completeresponse rates (pCR), and higher negative surgical margin rates [2,3,4,5]. Neoadjuvant …
J Shin, N Seo, SE Baek, NH Son, JS Lim, NK Kim… - Radiology, 2022 - pubs.rsna.org
… radiomics model performed better than visual assessment by experienced radiologists for diagnosing pathologiccompleteresponse … rectal cancer after neoadjuvantchemoradiotherapy. …
L Wen, J Liu, P Hu, F Bi, S Liu, L Jian, S Zhu, S Nie… - Academic …, 2023 - Elsevier
… (LARC) achieved pathologiccompleteresponse (pCR) to neoadjuvantchemoradiotherapy (nCRT) … We aimed to investigate the effectiveness of treatment response prediction using MRI-…
L Wan, W Peng, S Zou, F Ye, Y Geng, H Ouyang… - Academic …, 2021 - Elsevier
… In the present study, we developed and evaluated the performance of the delta-radiomics … in training and test sets, which were higher than that of mrTRG and delta-radiomics models …
C Li, H Chen, B Zhang, Y Fang, W Sun, D Wu, Z Su… - Cancers, 2023 - mdpi.com
… study was to evaluate the discriminative capabilities of radiomics signatures derived … radiomics signature capable of predicting pathologicalcompleteresponse (pCR) after neoadjuvant …
Y Hu, C Xie, H Yang, JWK Ho, J Wen, L Han… - JAMA network …, 2020 - jamanetwork.com
… Neoadjuvantchemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, …
M Zhang, Y Lu, H Sun, C Hou, Z Zhou, X Liu… - Translational …, 2024 - Elsevier
… pathology; (3) the availability of pre- and posttreatment CT scans for radiomicsanalysis; and (4) the availability of complete … ; (2) patients failed to complete therapy (radiation dose less …